Effect AT1 receptor blockade on cardiac collagen remodeling after myocardial infarction

Cardiovascular Research

Volumn 35, Issue 2, 1997, Pages 223-232

  Ju, Haisong ^a   Zhao, Shufang ^a   Jassal, Davinder S ^a   Dixon, Ian M C ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Collagen remodeling; Gene expression; Immunohistochemistry; Losartan; Myocardial infarction; Prolyl 4 hydroxylase; Rat, ventricle

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; COLLAGEN TYPE 1; LOSARTAN; MESSENGER RNA; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; ANTIHYPERTENSIVE AGENT; BIOLOGICAL MARKER; COLLAGEN; HYDROXYPROLINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART INFARCTION; HEART INFARCTION SIZE; HEART VENTRICLE REMODELING; IMMUNOHISTOCHEMISTRY; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; RAT; RECEPTOR BLOCKING; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; METABOLISM; NORTHERN BLOTTING; PATHOLOGY; PH; SPRAGUE DAWLEY RAT;

ANGIOTENSIN II; ANIMALS; ANTIHYPERTENSIVE AGENTS; BIOLOGICAL MARKERS; BLOTTING, NORTHERN; COLLAGEN; HYDROGEN-ION CONCENTRATION; HYDROXYPROLINE; IMMUNOHISTOCHEMISTRY; LOSARTAN; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ANGIOTENSIN; RNA, MESSENGER; VENTRICULAR FUNCTION, LEFT;

EID: 0030613010     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(97)00130-2     Document Type: Article

References (48)

1. Pelouch V, Dixon IMC, Sethi R, Dhalla NS. Alteration of protein profile in congestive heart failure secondary to myocardial infarction. Mol Cell Biochem 1993;129:121-131.
2. McCormick RJ, Musch TI, Bergman BC, Thomas DP. Regional differences in LV collagen accumulation and mature cross-linking after myocardial infarction in rats. Am J Physiol 1994;266:H354-H359.
3. Cleutjens JPM, Verluyten MJA, Smits JFM, Daemen MJAP. Collagen remodeling after myocardial infarction in the rat heart. Am J Pathol 1995;147:325-338.
4. Volders PAG, Willems IEMG, Cleutjens JPM, Arends J-W, Havenith MG, Daemen MJAP. Interstitial collagen is increased in the non-infarcted human myocardium after myocardial infarction. J Mol Cell Cardiol 1993;25:1317-1323.
5. Pelouch V, Dixon IMC, Golfman L, Beamish RE, Dhalla NS. Role of extracellular matrix proteins in heart function. Mol Cell Biochem 1993;129:101-102.
6. Ju H, Dixon IMC. The cardiac extracellular matrix and its role in the development of heart failure. In: Singal PK, Dixon IMC, Beamish RE, Dhalla NS, editors. Mechanisms of heart failure. Boston: Kluwer Academic Publishers, 1995:75-90.
7. Dixon IMC, Ju H, Jassal DS, Peterson DJ. Effect of ramipril and losartan on collagen expression in right and left heart after myocardial infarction. Mol Cell Biochem 1996; 165:31-45.
8. Schaper J, Speiser B. The extracellular matrix in the failing human heart. Basic Res Cardiol 1992;87(suppl 1):303-309.
9. Sabbah HN, Sharov VG, Lesch M, Goldstein S. Progression of heart failure: A role for interstitial fibrosis. Mol Cell Biochem 1995;147:29-34.
10. Litwin SE, Litwin CM, Raya TE, Warner AL, Goldman S. Contractility and stiffness of noninfarcted myocardium after coronary ligation in rats. Circulation 1991;83:1028-1037.
11. Pfeffer JM, Fischer TA, Pfeffer MA. Angiotensin-converting enzyme inhibition and ventricular remodeling after myocardial infarction. Annu Rev Physiol 1995;57:805-826.
12. Eleftheriades EG, Durand J-B, Ferguson AG, Engelmann GL, Jones SB, Samarel AM. Regulation of procollagen metabolism in the pressure-overloaded rat heart. J Clin Invest 1993;91:1113-1122.
13. Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD. Cell junction, cell adhesion, and the extracellular matrix. In: Molecular biology of the cell. New York and London: Garland Publishing, Inc., 1994:972-1000.
14. Eleftheriades EGie, Ferguson AG, Spragia ML, Samarel AM. Prolyl hydroxylation regulates procollagen degradation in cultured rat cardiac fibroblasts. J Mol Cell Cardiol 1995;27:1459-1473.
15. Hokimoto S, Yasue H, Fujimoto K, et al. Expression of angiotensin-converting enzyme in remaining viable myocytes of human ventricles after myocardial fibrosis. Circulation 1996;94:1513-1518.
16. Sun Y, Cleutjens JPM, Diaz-Arias AA, Weber KT. Cardiac angiotensin converting enzyme and myocardial fibrosis in the rat. Cardiovasc Res 1994;28:1423-1432.
17. Booz GW, Baker KM. Molecular signalling mechanisms controlling growth and function of cardiac fibroblasts. Cardiovasc Res 1995;30:537-543.
18. Weber KT. Cardiac interstitium in health and disease: the fibrillar collagen network. J Am Coll Cardiol 1989;13:1637-1652.
19. Van Krimpen C, Smits JFM, Cleutjens JPM, et al. DNA synthesis in the non-infarcted cardiac interstitium is increased after left coronary artery ligation in the rat: effects of captopril. J Mol Cell Cardiol 1991;23:1245-1253.
20. Michel JB, Lattion AL, Salzmann JL, et al. Hormonal and cardiac effects of converting enzyme inhibition in rat myocardial infarction. Circ Res 1988;62:641-650.
21. Smits JFM, van Krimpen C, Schoemaker RG, Cleutjens JPM, Daemon MJAP. Angiotensin II receptor blockade after myocardial infarction in rats: effects on hemodynamics, myocardial DNA synthesis, and interstitial collagen content. J Cardiovasc Pharmacol 1992;20:772-778.
22. Schieffer B, Wirger A, Meybrunn M, et al. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat. Circulation 1994;89:2273-2282.
23. Dixon IMC, Lee SL, Dhalla NS. Nitrendipine binding in congestive heart failure due to myocardial infarction. Circ Res 1990;66:782-788.
24. Makino N, Hata T, Sugano M, Dixon IMC, Yanaga T. Regression of hypertrophy after myocardial infarction is produced by the chronic blockade of angiotensin type 1 receptor in rats. J Mol Cell Cardiol 1996;28:507-517.
25. Chiariello M, Ambrosio G, Cappelli-Bigazzi M, Perrone-Filardi P, Brigante F, Sifola C. A biochemical method for the quantitation of myocardial scarring after experimental coronary artery occlusion. J Mol Cell Cardiol 1986;18:283-290.
26. Polak JM, Noorden SV. An introduction to immunocytochemistry: current techniques and problems. Microsc Handb 1984;11:1-49.
27. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
28. Chu ML, Myers JC, Bernard MP, Ding JF, Ramirez F. Cloning and characterization of five overlapping cDNA specific for the human pro-α1(I) collagen chain. Nucleic Acids Res 1982;10:5925-5934.
29. Chu ML, Weil D, de Wet W, Bernard M, Sippola M, Ramirez F. Isolation of cDNA and genomic clones encoding human pro-α1(III) collagen. J Biol Chem 1985;260:4357-4363.
30. Tso JY, Sun XH, Kao T, Reece KS, Wu R. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acids Res 1985;13:2485-2502.
31. Chan YL, Gutell LR, Noller HF, Wool IG. The nucleotide sequence of a rat 18S ribosomal ribonucleic acid gene and a proposal for the secondary structure of 18S ribosomal ribonucleic acid. J Biol Chem 1984;259:224-230.
32. Bai Y, Muragaki Y, Obata KI, Iwata K, Ooshima A. Immunological properties of monoclonal antibodies to human and rat prolyl 4-hydroxylase. J Biochem 1986;99:1563-1570.
33. Smith PK, Krohn RI, Hermanson GT, et al. Measurement of protein using bicinchoninic acid. Anal Biochem 1985;150:76-85.
34. Fisher SA, Periasamy M. Collagen synthesis inhibitors disrupt embryonic cardiocyte myofibrillogenesis and alter the expression of cardiac specific genes in vitro. J Mol Cell Cardiol 1994;26:721-731.
35. Yamagishi H, Kim S, Nishikimi T, Takeuchi K, Takeda T. Contribution of cardiac renin-angiotensin system to ventricular remodeling in myocardial-infarcted rats. J Mol Cell Cardiol 1993;25:1369-1380.
36. Meggs LG, Coupet J, Huang H, et al. Regulation of angiotensin II receptors on ventricular myocytes after myocardial infarction in rats. Circ Res 1993;72:1149-1162.
37. Steinberg M, Wiest SA, Palkowitz AD. Nonpeptide angiotensin II receptor antagonists. Cardiovasc Drugs Rev 1993;11:312-358.
38. Dostal DE, Baker KM. Biochemistry, molecular biology, and potential roles of the cardiac renin-angiotensin system. In: Dhalla NS, Beamish RE, Takeda N, Nagano M, editors. The failing heart. Philadelphia: Lippincott-Raven Publishers, 1995:275-294.
39. Booz GW, Baker KM. Molecular signalling mechanisms controlling growth and function of cardiac fibroblasts. Cardiovasc Res 1995;30:537-543.
40. Crabos M, Roth M, Hahn AWA, Erne P. Characterization of angiotensin II receptors in cultured adult rat cardiac fibroblasts. J Clin Invest 1994;93:2372-2378.
41. Liu Y-H, Yang X-P, Sharov VG, Carretero OA. The role of angiotensin II type 2 receptor in the effect of chronic blockade of angiotensin II type I receptor on heart failure in rats. Hypertension 1996;28:512.
42. Capasso JM, Li P, Meggs LG, Herman MV, Anversa P. Efficacy of angiotensin-converting enzyme inhibition and AT1 receptor blockade on cardiac pump performance after myocardial infarction in rats. J Cardiacvasc Pharmacol 1994;23:584-593.
43. Hanatani A, Yoshiyama M, Kim S, et al. Inhibition by angiotensin II type I receptor antagonist of cardiac phenotypic modulation after myocardial infarction. J Mol Cell Cardiol 1995;27:1905-1914.
44. Kim S, Ohta K, Hamaguchi A, et al. Angiotensin II type I receptor antagonist inhibits the gene expression of transforming growth factor-β1 and extracellular matrix in cardiac and vascular tissues of hypertensive rats. J Pharmacol Exp Ther 1995;273:509-515.
45. Eghbali M, Tomek R, Sukhatme VP, Woods C, Bhambi B. Different effects of transforming growth factors and phorbol myristate acetate on cardiac fibroblasts. Regulation of fibrillar collagen mRNAs and expression of early transcription factors. Circ Res 1991;69:483-490.
46. Ju H, Dixon IMC. Effect of angiotensin II on myocardial collagen gene expression. Mol Cell Biochem 1996;163/164:231-237.
47. Besse S, Robert V, Assayag P, Delcayre C, Swynghedauw B. Nonsynchronous changes in myocardial collagen mRNA and protein during aging: effect of DOCA-salt hypertension. Am J Physiol 1994;267:H2237-H2244.
48. Mays PK, McAnulty RJ, Campa JS, Laurent GJ. Age-related changes in collagen synthesis and degradation in rats tissues. Biochem J 1991;276:307-313.